Finance

Beta
Lists
RMD:ASX
Resmed CDI
26,58 AUD
-7,55%
(-2,17) 1D
1-июн., 13:38:51 GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RMD...
Open
26,79 AUD
High
26,79 AUD
Low
26,34 AUD
Mkt. cap
27,64 млд
Avg. vol.
1,42 млн
Volume
1,97 млн
52-wk high
45,25 AUD
52-wk low
26,34 AUD
Shares outstanding
145,06 млн
No. of employees
11 миң
Open
26,79 AUD
High
26,79 AUD
Low
26,34 AUD
Mkt. cap
27,64 млд
Avg. vol.
1,42 млн
Volume
1,97 млн
52-wk high
45,25 AUD
52-wk low
26,34 AUD
Shares outstanding
145,06 млн
No. of employees
11 миң
News stories
From sources across the web
Profile
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed CDI
CEOMichael J. Farrell
Employees10,6 миң
Foundedиюн. 1989
HeadquartersСан Диего, Калифорния, Америка Кошмо Штаттары
SectorMedical device
Websiteresmed.com
Last report
2026-ж., 30-апр.
Fiscal period
Q3 2026
EPS / Est. (USD)
0,29 USD / 2,80 USD
-89,79%miss
Revenue / Est. (USD)
1,43 млд / 1,42 млд
+0,63%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
1,35 млд
1,34 млд
1,42 млд
1,43 млд
Cost of goods sold
518,56 млн
506,94 млн
536,28 млн
532,58 млн
Cost of revenue
518,56 млн
506,94 млн
536,28 млн
532,58 млн
Research and development expenses
86,44 млн
87,32 млн
90,97 млн
94,27 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
265,12 млн
259,19 млн
275,70 млн
279,80 млн
Operating expense
372,86 млн
366,29 млн
386,24 млн
393,16 млн
Total operating expenses
891,42 млн
873,24 млн
922,51 млн
925,74 млн
Operating income
456,57 млн
462,35 млн
500,30 млн
505,67 млн
Other non operating income
-36,00 миң
-3,84 млн
42,00 миң
181,00 миң
EBT including unusual items
458,05 млн
446,79 млн
496,15 млн
502,31 млн
EBT excluding unusual items
462,62 млн
468,79 млн
504,48 млн
518,30 млн
Income tax expense
78,35 млн
98,26 млн
103,56 млн
103,58 млн
Effective tax rate
17,10%
21,99%
20,87%
20,62%
Other operating expenses
-
-
-
-
Net income
379,70 млн
348,54 млн
392,59 млн
398,73 млн
Net profit margin
28,17%
26,10%
27,59%
27,86%
Earnings per share
2,55
2,55
2,81
0,29
Interest and investment income
9,57 млн
4,69 млн
4,46 млн
3,80 млн
Interest expense
-
-
-
-
Net interest expenses
9,57 млн
4,69 млн
4,46 млн
3,80 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
513,86 млн
503,64 млн
543,79 млн
558,22 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer